Trial Profile
Effect of telmisartan on insulin resistance with hypertensive patients older than 65 years old.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2013
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension; Insulin resistance; Metabolic syndrome
- Focus Therapeutic Use
- 17 Jan 2013 New trial record